Savara Reports Third Quarter 2022 Financial Results and Provides Business Update

Author's Avatar
Nov 10, 2022

Savara+Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, reported financial results for the third quarter ending September 30, 2022 and provided a business update.